Pfizer Academic Program HQ in Cambridge

Xconomy Boston — 

Drug giant Pfizer (NYSE: PFE) announced today that it is establishing an entrepreneurship partner network with academic medical research centers, called the Global Centers for Therapeutic Innovation, to be headquartered in Cambridge, MA. Yesterday Luke reported that UC San Francisco had inked a deal through the program, in which Pfizer could pay up to $85 million over five years to help get discoveries made at the school to market. The Global Centers program will first focus on U.S. institutions and later transition to also develop partnerships abroad, and will be led by Anthony Coyle, a former executive at AstraZeneca’s MedImmune Biologics division.